Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Access to orphan drugs for rare cancers in EU28

Although the economic burden imposed by rare cancers has not yet been adequately assessed, the treatment burden posed by rare cancers on individuals, societies and healthcare systems make them a...

- PMLiVE

Alex Ledger becomes Decideum Health’s deputy managing director

Mia Ayres, Kate Young and Katie Agius also join the consultancy

- PMLiVE

Merck gets early OK for Keytruda in first-line lung cancer

FDA fast-tracks approval of PD-1/PD-L1 inhibitor for treatment of NSCLC

- PMLiVE

GSK’s blockbuster hopeful Shingrix filed in US

Clinical data showed shingles vaccine had 90% efficacy in elderly patients

- PMLiVE

Overriding the main frame

Leveraging behavioural biases to our advantage

- PMLiVE

Dr Li Zhou joins TxCell as cell engineering VP

Brings experience from Novartis and ZMKS

- PMLiVE

Pharma ‘could do better’ on social media engagement

Industry is comfortable with the tech but has work to do on its approach

- PMLiVE

Astronauts to trial healthcare wearables in space

Canadian Space Agency plans to test a 'smart shirt' in an upcoming mission

- PMLiVE

After delay, Merck gets US approval for serious infection drug

Zinplava anticipated to accrue $300m in sales by 2020

Bristol-Myers Squibb (BMS) building

Keytruda, Opdivo narrow Tecentriq’s lead in bladder cancer

BMS’ drug is currently under FDA and EMA review in advanced urothelial carcinoma

- PMLiVE

Pharma Perspectives: The agency selection process (part 2)

AstraZeneca's Samuel Hollis on the evolution of the agency selection process

- PMLiVE

Consilium appoints executive consultants

Cameron Standage and Rosie Phillips join the healthcare consultancy

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links